You are here

MS

Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients

Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients

Endpoints

multiple sclerosis

clinical trials

Flag link:

Here's a Multibillion-Dollar Market for Johnson & Johnson

Here's a Multibillion-Dollar Market for Johnson & Johnson

Motley Fool

multiple sclerosis

Flag link:

Helius Medical’s device gets FDA all clear to stimulate the brain via the tongue

Helius Medical’s device gets FDA all clear to stimulate the brain via the tongue

MedCity News

brain stimulation

multiple sclerosis

Flag link:

BrainStorm Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis

BrainStorm Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis

BioSpace

BrainStorm Cell Therapeutics

clinical trials

multiple sclerosis

Flag link:

FDA approves Janssen’s PONVORY for treatment of multiple sclerosis

FDA approves Janssen’s PONVORY for treatment of multiple sclerosis

Pharmaceutical Business Review

relapsing multiple sclerosis

Flag link:

J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market

J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market

Fierce Pharma

Bristol-Myers Squibb

multiple sclerosis

Flag link:

Bristol Myers Squibb's MS innovation challenge winners tap technology for patients

Bristol Myers Squibb's MS innovation challenge winners tap technology for patients

Fierce Pharma

Bristol-Myers Squibb

multiple sclerosis

Evolution Devices

aritificial intelligence

Flag link:

Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity

Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity

Endpoints

multiple sclerosis

Flag link:

Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease of use

Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease of use

Fierce Pharma

multiple sclerosis

Flag link:

MS study points to the gut microbiome as a potential source of the disease

MS study points to the gut microbiome as a potential source of the disease

Fierce Biotech

multiple sclerosis

Flag link:

Biogen to pay $22 million to resolve U.S. drug charity kickback probe

Biogen to pay $22 million to resolve U.S. drug charity kickback probe

Reuters

multiple sclerosis

Flag link:

Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion

Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion

Fierce Pharma

multiple sclerosis

Flag link:

TG adds a multiple sclerosis string to its bow

TG adds a multiple sclerosis string to its bow

EP Vantage

TG Therapeutics

multiple sclerosis

Flag link:

MediciNova's Ibudilast Reduces Retinal Thinning in MS Trial Subjects

MediciNova's Ibudilast Reduces Retinal Thinning in MS Trial Subjects

BioSpace

clinical trials

multiple sclerosis

retinal thinning

Flag link:

Biogen finally culls MS dud opicinumab, adds SMA gene therapy to the garbage heap

Biogen finally culls MS dud opicinumab, adds SMA gene therapy to the garbage heap

Fierce Biotech

Flag link:

'Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone

'Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone

Fierce Pharma

Teva Pharmaceutical

Flag link:

Novartis set to take on Roche as FDA clears first at-home, injectable MS drug

Novartis set to take on Roche as FDA clears first at-home, injectable MS drug

Biopharma Dive

multiple sclerosis

Flag link:

Teva shares slide as it faces illegal kickback charges from US government

Teva shares slide as it faces illegal kickback charges from US government

Pharmaforum

Teva Pharmaceutical

multiple sclerosis

Flag link:

Mylan launches first generic to Tecfidera in multiple sclerosis

Mylan launches first generic to Tecfidera in multiple sclerosis

Seeking Alpha

multiple sclerosis

Flag link:

U.S. court upholds patent for Novartis MS drug Gilenya

U.S. court upholds patent for Novartis MS drug Gilenya

Reuters

multiple sclerosis

Flag link:

Pages